ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP33-26 Update for New-to-Market Medical Drugs: lunsotogene parvec-cwha
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 13, 2026
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 4151 - 4160 လၢ 4303 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP32-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2026
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 13, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP31-26 MHCP Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 13, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP30-26 Commercial Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 13, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP38-26 MHCP Pharmacy Benefit Exclusion for Avopef™, Epioxa™ HD/Epioxa, Fesilty™, Midazolam, Photrexa®, and Wainua®
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 27, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP37-26 Commercial Pharmacy Benefit Exclusion for Epioxa™ HD/Epioxa, Fensolvi®, Fesilty™, Midazolam, Photrexa®, Wainua®, Zemaira®, and Zoladex®
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 27, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP36-26 Commercial Pharmacy Benefit Exclusion for Select Medications
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 27, 2026